ENTRY       D03365                      Drug
NAME        Nicotine (USP);
            Habitrol (TN)
PRODUCT     NICOTROL (Pharmacia & Upjohn Company LLC)
            NICOTROL (Pharmacia & Upjohn Company LLC)
FORMULA     C10H14N2
EXACT_MASS  162.1157
MOL_WEIGHT  162.2316
CLASS       Metabolizing enzyme substrate
             DG01638  CYP2A6 substrate
            Metabolizing enzyme inducer
             DG01637  CYP1A2 inducer
REMARK      Same as: C00745
            Therapeutic category: 7990
            ATC code: N07BA01
            Chemical structure group: DG00994
            Product (DG00994): D03365<JP/US>
EFFICACY    Smoking cessation adjunct
TARGET      CHRN [HSA:1134 1135 1136 1137 1138 8973 1139 55584 57053 1140 1141 1142 1143 1144 1145 1146] [KO:K04803 K04804 K04805 K04806 K04807 K04808 K04809 K04810 K04811 K04812 K04813 K04814 K04815 K04816 K04817 K04818]
  PATHWAY   hsa04080(1134+1135+1136+1137+1138+1139+1140+1141+1142+1143+1144+1145+1146+55584+57053+8973)  Neuroactive ligand-receptor interaction
            hsa04725(1136+1137+1139+1141+1143+8973)  Cholinergic synapse
            hsa05033(1137+1139+1141+8973)  Nicotine addiction
METABOLISM  Enzyme: CYP2A6 [HSA:1548]
INTERACTION CYP induction: CYP1A2 [HSA:1544]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N07 OTHER NERVOUS SYSTEM DRUGS
               N07B DRUGS USED IN ADDICTIVE DISORDERS
                N07BA Drugs used in nicotine dependence
                 N07BA01 Nicotine
                  D03365  Nicotine (USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Anti-Addiction/Substance Abuse Treatment Agents
              Smoking Cessation Agents
               Nicotine
                D03365  Nicotine (USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             7  Agents not mainly for therapeutic purpose
              79  Other agents not mainly for therapeutic purpose
               799  Miscellaneous
                7990  Miscellaneous
                 D03365  Nicotine (USP)
            Classification of Japanese OTC drugs [BR:br08313]
             Stop smoking aid
              77 Stop smoking aid
               D03365  Nicotine (USP)
            Risk category of Japanese OTC drugs [BR:br08312]
             First-class OTC drugs
              Inorganic and organic chemicals
               Nicotine
                D03365  Nicotine (USP)
             Designated second-class OTC drugs
              Inorganic and organic chemicals
               Nicotine
                D03365  Nicotine (USP)
             Second-class OTC drugs
              Inorganic and organic chemicals
               Nicotine
                D03365  Nicotine (USP)
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01638  CYP2A6 substrate
               DG00994  Nicotine
                D03365  Nicotine
             Metabolizing enzyme inducer
              DG01637  CYP1A2 inducer
               DG00994  Nicotine
                D03365  Nicotine
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Ligand-gated ion channels
               Acetylcholine (nicotinic)
                CHRN
                 D03365  Nicotine (USP) &lt;JP/US&gt;
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D03365
            Rx-to-OTC switch list in the USA [br08315.html]
             D03365
            Rx-to-OTC switch list in Japan [br08314.html]
             D03365
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01638  CYP2A6 substrate
               DG00994  Nicotine
             Metabolizing enzyme inducer
              DG01637  CYP1A2 inducer
               DG00994  Nicotine
DBLINKS     CAS: 54-11-5
            PubChem: 17397514
            ChEBI: 17688
            PDB-CCD: NCT
            LigandBox: D03365
            NIKKAJI: J9.266E
ATOM        12
            1   C8x C    29.1341  -17.6496
            2   C8x C    29.1341  -19.0503
            3   N5x N    30.3471  -19.7507
            4   C8x C    31.5602  -19.0503
            5   C8y C    31.5602  -17.6496
            6   C8x C    30.3471  -16.9493
            7   C1y C    32.7920  -16.9383
            8   C1x C    34.1270  -17.3204
            9   C1x C    34.9074  -16.1695
            10  C1x C    34.0540  -15.0718
            11  N1y N    32.7463  -15.5441
            12  C1a C    31.5702  -14.7465
BOND        13
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     7   5 1 #Up
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11   10  11 1
            12    7  11 1
            13   11  12 1
///
